title: Denosumab for post-transplantation hypercalcemia in osteopetrosis.
authors.forename: Rukshana
authors.initials: R
authors.lastname: Shroff
authors.forename: Ortraud
authors.initials: O
authors.lastname: Beringer
authors.forename: Kanchan
authors.initials: K
authors.lastname: Rao
authors.forename: Lorenz C
authors.initials: LC
authors.lastname: Hofbauer
authors.forename: Ansgar
authors.initials: A
authors.lastname: Schulz
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D000069448:Denosumab; D017809:Fatal Outcome; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D010022:Osteopetrosis / Q000628:therapy*; D053245:RANK Ligand / Q000037:antagonists & inhibitors*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D053245:RANK Ligand; C505688:TNFSF11 protein, human; D000069448:Denosumab